| Application no. and date | 02744835.6 (espacenet) (Federated) (European Patent Register), 20020703 | | Patent/reg. no. and date | DK/EP 1404331, 20071031 | | Publication date | 20040407 | | Priority no. and date | US 303357 P, 20010706, US 329426 P, 20011015, US 329352 P, 20011015 | | EP pub. no. and date |
EP 1404331 20040407 | | Effective date | | | Applicant/owner | Penwest Pharmaceuticals Co., 2981 Route 22
Patterson, NY 12563-9970, US | | Applicant ref. no. | P43214DK01 | | Inventor | KAO, Huai-Hung, 137 Colony Lane
Syosset, NY 11791, US,
BAICHWAL, Anand, R., 5 Kendell Drive
Wappingers Falls, NY 12590, US,
MCCALL, Troy, W., 8861 Three Chimneys Drive East
Germantown, TN 38138, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/485 (2006.01) , A61K 9/20 (2006.01) , A61P 25/04 (2006.01) | | Title | Sustained release-formuleringer af oxymorphon | | Int. application no. | US2002021403 | | Int. publication no. | WO2003004033 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
